Nuvectis Pharma, Inc. (NVCT)
21.08
+0.06
(+0.29%)
USD |
NASDAQ |
Nov 10, 16:00
21.19
+0.11
(+0.52%)
After-Hours: 20:00
Nuvectis Pharma Total Assets (Quarterly) : 140.84M for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 140.84M |
| June 30, 2026 | 22.38M |
| March 31, 2026 | 25.40M |
| December 31, 2025 | 31.71M |
| September 30, 2025 | 35.59M |
| June 30, 2025 | 27.01M |
| March 31, 2025 | 30.15M |
| December 31, 2024 | 18.61M |
| September 30, 2024 | 17.31M |
| June 30, 2024 | 18.30M |
| March 31, 2024 | 19.71M |
| December 31, 2023 | 19.18M |
| Date | Value |
|---|---|
| September 30, 2023 | 22.26M |
| June 30, 2023 | 24.94M |
| March 31, 2023 | 16.21M |
| December 31, 2022 | 20.40M |
| September 30, 2022 | 24.87M |
| June 30, 2022 | 14.24M |
| March 31, 2022 | 17.62M |
| December 31, 2021 | 6.657M |
| September 30, 2021 | 6.809M |
| June 30, 2021 | 7.214M |
| March 31, 2021 | 0.00 |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Opus Genetics, Inc. | 95.30M |
| Faeth Therapeutics, Inc. | 178.95M |
| ACADIA Pharmaceuticals, Inc. | 1.794B |
| Alnylam Pharmaceuticals, Inc. | 7.995B |
| Anika Therapeutics, Inc. | 189.60M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 14.19M |
| Shareholders Equity (Quarterly) | 126.65M |
| Current Ratio | 9.923 |